Prognostic impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer
Results show that post-treatment circulating tumor RAS and BRAF MT dynamics may serve as useful prognostic indicators, particularly with regard to BRAF MT.